Antimicrobial activity of HR810 against 419 strict anaerobic bacteria
- 1 March 1985
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 27 (3), 413-415
- https://doi.org/10.1128/aac.27.3.413
Abstract
HR810 and four other new beta-lactams were tested against 419 recent clinical anaerobic bacterial isolates. HR810 was found to have an antimicrobial spectrum most similar to that of cefotaxime, inhibiting 52.6% of Bacteroides fragilis group strains and 97.2% of all other anaerobic strains at an MIC of less than or equal to 16 micrograms/ml. Cefoxitin was found to have a narrower antimicrobial spectrum against the gram-positive anaerobic bacteria (8.4 to 10.1% less) than HR810 and cefotaxime, respectively.Keywords
This publication has 8 references indexed in Scilit:
- The activity of cefotaxime and desacetylcefotaxime alone and in combination against anaerobes and staphylococci.1984
- In vitro evaluation of HR810, a new wide-spectrum aminothiazolyl alpha-methoxyimino cephalosporinAntimicrobial Agents and Chemotherapy, 1984
- Cefoxitin inactivation by Bacteroides fragilisAntimicrobial Agents and Chemotherapy, 1983
- Susceptibility of gram-positive aerobic cocci to the new cephalosporin HR 810European Journal of Clinical Microbiology & Infectious Diseases, 1983
- HR 810, a cephalosporin with low affinity forEnterobacter cloacae beta-lactamaseEuropean Journal of Clinical Microbiology & Infectious Diseases, 1983
- Susceptibility of the Bacteroides fragilis group in the United States in 1981Antimicrobial Agents and Chemotherapy, 1983
- HR 810, a new parenteral cephalosporin with a broad antibacterial spectrum.1983
- The activity of nitro-compounds against Bacteroides fragilis is related to their electron affinityJournal of Antimicrobial Chemotherapy, 1981